167 related articles for article (PubMed ID: 6450239)
21. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
22. Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines.
Zarling JM; Bach FH
J Exp Med; 1978 May; 147(5):1334-40. PubMed ID: 206649
[TBL] [Abstract][Full Text] [Related]
23. Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells.
Trinchieri G; Santoli D; Granato D; Perussia B
Fed Proc; 1981 Oct; 40(12):2705-10. PubMed ID: 6169557
[TBL] [Abstract][Full Text] [Related]
24. Generation of cytotoxic lymphocytes in the autologous mixed lymphocyte culture.
Miller RA; Kaplan HS
J Immunol; 1978 Dec; 121(6):2165-7. PubMed ID: 152788
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxicity of human peripheral lymphocytes in cell-mediated lympholysis; antibody-dependent cell-mediated lympholysis and natural cytotoxicity assays after mixed lymphocyte culture.
Callewaert DM; Lightbody JJ; Kaplan J; Jaroszewski J; Peterson WD; Rosenberg JC
J Immunol; 1978 Jul; 121(1):81-5. PubMed ID: 149818
[TBL] [Abstract][Full Text] [Related]
26. The lymphocyte subpopulations involved in cytotoxicity generated by co-culture with autologous and allogeneic Epstein-Barr virus-transformed cell line.
Minakuchi J; Yata J
Tohoku J Exp Med; 1988 Jun; 155(2):107-15. PubMed ID: 2850641
[TBL] [Abstract][Full Text] [Related]
27. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of NK-like cells from OKT3-, OKT11+, and OKM1+ small resting lymphocytes by culture with autologous T cell blasts and lymphokine.
Warren HS
J Immunol; 1984 Jun; 132(6):2888-94. PubMed ID: 6233364
[TBL] [Abstract][Full Text] [Related]
29. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
30. Alloantigen-induced enhancement and suppression of human cytotoxic lymphocyte responses to autologous lymphoblastoid cell lines.
Zarling JM; Bach FH
Scand J Immunol; 1978; 8(5):377-85. PubMed ID: 152971
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic T cells generated in the autologous mixed lymphocyte reaction. I. Primary autologous mixed lymphocyte reaction.
Tomonari K
J Immunol; 1980 Mar; 124(3):1111-21. PubMed ID: 6444646
[TBL] [Abstract][Full Text] [Related]
32. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
[TBL] [Abstract][Full Text] [Related]
33. Natural killer cells inhibit outgrowth of autologous Epstein-Barr virus-infected B lymphocytes.
Kaplan J; Shope TC
Nat Immun Cell Growth Regul; 1985; 4(1):40-7. PubMed ID: 2993873
[TBL] [Abstract][Full Text] [Related]
34. Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targets.
Ramos OF; Algarra I; Sármay G; Yefenof E; Gergely J; Klein E
J Immunol; 1989 Jan; 142(1):217-23. PubMed ID: 2521233
[TBL] [Abstract][Full Text] [Related]
35. In vitro generation of NK-like activity in human PBL co-cultured with fresh T leukaemia cells.
Matera L; Foa R; Moore M
J Clin Lab Immunol; 1984 Oct; 15(2):85-90. PubMed ID: 6335181
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the alloactivated E+Ia+ cell capable of stimulating in mixed lymphocyte culture.
Shen HH; Irigoyen O; Friedman SM; Chess L
J Immunol; 1982 Jan; 128(1):501-5. PubMed ID: 6459379
[TBL] [Abstract][Full Text] [Related]
37. Generation of long-term human cytolytic cell lines with persistent natural killer activity.
Krensky AM; Ault KA; Reiss CS; Strominger JL; Burakoff SJ
J Immunol; 1982 Oct; 129(4):1748-51. PubMed ID: 6286775
[TBL] [Abstract][Full Text] [Related]
38. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
Klingemann HG; Wong E; Maki G
Biol Blood Marrow Transplant; 1996 May; 2(2):68-75. PubMed ID: 9118301
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro.
Ware CF; Granger GA
J Immunol; 1981 May; 126(5):1919-26. PubMed ID: 6452481
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
